Author： Pistoia Francesca Mura Elisa
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.24, Iss.8, 2010-08, pp. : 625-638
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Willingness-to-pay a better measure to value drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. :
Access to resources
Recommend
Why do Americans pay more for drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 601, 2010-01 ,pp. :
MicroRNA: Potential Targets for the Development of Novel Drugs?
By Wu Wei
Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. :
How Well Tolerated Are Lipid-Lowering Drugs?
By Tomlinson B.
Drugs & Aging, Vol. 18, Iss. 9, 2001-01 ,pp. :
Is the UK government delaying approval for new cancer drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. :